A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG) için istatistikler
Toplam ziyaret
views | |
---|---|
A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG) | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ocak 2024 | 0 |
Şubat 2024 | 0 |
Mart 2024 | 0 |
Nisan 2024 | 0 |
Mayıs 2024 | 0 |
Haziran 2024 | 0 |
Temmuz 2024 | 0 |